Dermatol. praxi. 2026;20(2):60-64 | DOI: 10.36290/der.2026.010

Trends in acne treatment in adolescents

MUDr. Anna Hrazdírová
Dětské kožní oddělení, Pediatrická klinika, FN Brno a LF MU v Brně

Acne is one of the most common dermatological conditions of adolescence, significantly affecting the quality of life of patients. Current trends in treatment emphasize the early use of topical retinoids, the use of fixed-dose combinations, earlier initiation of oral isotretinoin, and the limited use of antibiotic therapy. Dermocosmetic care is an important part of the treatment as well. Minimally invasive aesthetic procedures are increasingly used in the management of acne sequelae, particularly scars and post-inflammatory pigmentation. The treatment should be individualized, simple, and targeted not only at active manifestations of the disease, but also at preventing long-term consequences.

Keywords: acne vulgaris, adolescence, topical retinoids, isotretinoin, fixed-dose combination, antibiotic resistance, dermocosmetics, hormonal therapy, acne patches, clascoterone.

Accepted: June 8, 2026; Published: June 18, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hrazdírová A. Trends in acne treatment in adolescents. Dermatol. praxi. 2026;20(2):60-64. doi: 10.36290/der.2026.010.
Download citation

References

  1. Eichenfield DZ, Sprague J, Eichenfield LF. Management of Acne Vulgaris: A Review. JAMA. 2021;326(20):2055-67. Go to original source...
  2. Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of Care for the Management of Acne Vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1-1006.e30. Go to original source...
  3. Zaenglein AL. Acne Vulgaris. N Engl J Med. 2018;379(14):1343-52. Go to original source... Go to PubMed...
  4. Williams HC, Dellavalle RP, Garner S. Acne Vulgaris. Lancet. 2012;379(9813):361-72. Go to original source...
  5. Adler BL, Kornmehl H, Armstrong AW. Antibiotic Resistance in Acne Treatment. JAMA Dermatol. 2017;153(8):810-1. Go to original source... Go to PubMed...
  6. Nelson M. Acne Management: Guidelines From the American Academy of Dermatology. Am Fam Physician. 2025;112(5):574-6.
  7. Gollnick HP, Draelos Z, Glenn MJ, et al. Adapalene-Benzoyl Peroxide, a Unique Fixed-Dose Combination Topical Gel for the Treatment of Acne Vulgaris: A Transatlantic, Randomized, Double-Blind, Controlled Study in 1670 Patients. Br J Dermatol. 2009;161(5):1180-9. Go to original source...
  8. Thiboutot D, Layton AM, Traore I, et al. International Expert Consensus Recommendations for the Use of Dermocosmetics in Acne. J Eur Acad Dermatol Venereol. 2025;39(5):952-66. Go to original source... Go to PubMed...
  9. Nevoralová Z. Izotretinoin v praxi. 2. aktualizované a rozšířené vydání. Praha: EEZY;2025.
  10. Jaturapisanukul K, Udompataikul M, Kanokrungsee S, et al. Efficacy and Safety of a Novel Water-Soluble Herbal Patch for Acne Vulgaris Treatment: A Randomized, Assessor-Blinds Controlled, Intra-Individual Split-Face Comparative Study. Dermatol Ther. 2021;34(3):e14925. Go to original source...
  11. Mujahid N, Shareef F, Maymone MBC, et al. Microneedling as a Treatment for Acne Scarring: A Systematic Review. Dermatol Surg. 2020;46(1):86-92. Go to original source...
  12. Shen YC, Chiu WK, Kang YN, et al. Microneedling Monotherapy for Acne Scar: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Aesthetic Plast Surg. 2022;46(4):1913-22. Go to original source...
  13. Dayal S, Kaur R, Sahu P. Efficacy of Microneedling With 35% Glycolic Acid Peels Versus Microneedling With 15% Trichloroacetic Acid Peels in Treatment of Atrophic Acne Scars: A Randomized Controlled Trial. Dermatol Surg. 2022;48(11):1203-9. Go to original source...
  14. Renzi M, McLarney M, Jennings T, et al. Procedural and Surgical Treatment Modalities for Acne Scarring: Part II. J Am Acad Dermatol. 2024;90(6):1137-50. Go to original source... Go to PubMed...
  15. Shields A, Ly S, Wafae B, et al. Safety and Effectiveness of Oral Nutraceuticals for Treating Acne: A Systematic Review. JAMA Dermatol. 2023;159(12):1373-82. Go to original source... Go to PubMed...
  16. Sánchez-Pellicer P, Navarro-Moratalla L, Núñez-Delegido E, et al. Acne, Microbiome, and Probiotics: The Gut-Skin Axis. Microorganisms. 2022;10(7):1303. Go to original source...
  17. Dhillon S. Clascoterone: First Approval. Drugs. 2020;80(16):1745-50. Go to original source...
  18. Peterson H, Kircik L, Armstrong AW. Individual Article: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne. J Drugs Dermatol. 2023;22(6):SF350992s7-SF350992s14.
  19. Hebert A, Thiboutot D, Stein Gold L, et al. Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials. JAMA Dermatol. 2020;156(6):621-30. Go to original source...
  20. Kalabalik-Hoganson J, Frey KM, Ozdener-Poyraz AE, et al. Clascoterone: A Novel Topical Androgen Receptor Inhibitor for the Treatment of Acne. Ann Pharmacother. 2021;55(10):1290-6. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.